Regions Financial Corp
XMUN:RN7
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
R
|
Regions Financial Corp
XMUN:RN7
|
US |
|
C
|
Compass Therapeutics Inc.
NASDAQ:CMPX
|
US |
|
M
|
Montauk Metals Inc
XTSX:MTK
|
CA |
|
Pharmaust Ltd
ASX:PAA
|
AU |
|
P
|
President Bakery PCL
SET:PB
|
TH |
|
Celanese Corp
NYSE:CE
|
US |
|
Valuence Merger Corp I
NASDAQ:VMCA
|
US |
|
E
|
eBay Inc
XMUN:EBA
|
US |
|
C
|
CG Oncology Inc
NASDAQ:CGON
|
US |
|
Energia Innovacion y Desarrollo Fotovoltaico SA
MAD:EIDF
|
ES |
Wall St Price Targets
RN7 Price Targets Summary
Regions Financial Corp
According to Wall Street analysts, the average 1-year price target for RN7 is 29.071 EUR with a low forecast of 24.435 EUR and a high forecast of 32.66 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is RN7's stock price target?
Price Target
29.071
EUR
According to Wall Street analysts, the average 1-year price target for RN7 is 29.071 EUR with a low forecast of 24.435 EUR and a high forecast of 32.66 EUR.
What is the Revenue forecast for Regions Financial Corp?
Projected CAGR
5%
Over the last 13 years, the compound annual growth rate for Revenue has been 3%. The projected CAGR for the next 3 years is 5%.
What is the Net Income forecast for Regions Financial Corp?
Projected CAGR
3%
Over the last 13 years, the compound annual growth rate for Net Income has been 6%. The projected CAGR for the next 8 years is 3%.
